Unilever's 'Careful' Pricing Strategy Pays Off In Q1
Executive Summary
Unilever PLC says pricing is critical to enabling it to continue investing in brands as input cost inflation for the firm in 2022 is expected to reach almost €5bn. The British company increased pricing 8% across its portfolio, which includes skin care brand Dove and vitamin brand Olly, helping drive total underlying sales growth of 7.3% in the first quarter.
You may also be interested in...
Unilever Aims To Beat 2022 Growth Target While Wrangling Consumer Recession Fears
Unilever’s confidence is unshaken, though “the threat of recession is starting to impact consumer confidence and change in spending patterns and behaviors,” Unilever CEO Alan Jope acknowledged in a 26 July presentation on fiscal 2022 first-half results.
Unilever Targets Sustainable Palm Oil Alternative With $120m Biotech Deal
Unilever PLC partners with biotechnology company Genomatica to fund and scale plant-based alternatives to palm oil for personal care and cleaning products.
Unilever Targets Hair Health From Inside-Out With Nutrafol Acquisition
After five years with a minority interest in Nutrafol for “clinically proven hair growth,” Unilever will acquire a majority stake in the supplements brand under undisclosed terms. Nutrafol says its nutraceuticals for men and women – sold through multiple channels including by more than 3,000 physicians – target “the six root causes affecting hair health.”